Phase II trial of levocetirizine with capecitabine and bevacizumab to overcome the resistance of antiangiogenic therapies in refractory metastatic colorectal cancer
左西替利嗪联合卡培他滨和贝伐单抗治疗难治性转移性结直肠癌以克服抗血管生成疗法耐药性的II期临床试验
期刊:Journal of Gastrointestinal Oncology
影响因子:2
doi:10.21037/jgo.2019.02.01
Amin, Manik; Desai, Monica; Trinkaus, Kathryn; Brown, Amberly; Wang-Gillam, Andrea; Tan, Benjamin; Picus, Joel; Sorscher, Steven; Highkin, Maureen; Lears, Kim; Lockhart, Albert C